This afternoon, AMO provided their Submission to Health Canada's Cannabis Act legislative review. Municipal governments in Ontario and other jurisdictions have been expressing concerns over personal and designated medical cannabis production sites, particularly regarding the health and safety risks of production sites; lack of adherence to local planning requirements, zoning, building code standards, and permit requirements; and diversion of cannabis grown for medical purposes into the illicit market. 

AMO recommends that the Panel reach out to municipalities in Ontario and other provinces with recent municipal elections that have had issues with personal and designated medical cannabis grows in their communities for their input into the review.



Daniela Spagnuolo
Policy Advisor